Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-065820

Director sold 755 shares at $40.11 ($30,283)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Salter Malcolm Director 2021-11-19 Sale −755 $40.11 $30,283 11,707 D
Open-market sales · 755 sh · avg $40.11 · $30,283
Loading xslF345X03/doc4.xml…